Results
To examine the specific role of KLF10 in arterial reendothelialization, we first used wire-induced endothelial injury and validated that carotid artery endothelial denudation was achieved using independent strategies, including the following: (1) Evans blue staining; (2) silver nitrate perfusion staining 11 ; (3) staining for β-gal in Tie2-LacZ mice; and (4) scanning electron microscopy. As shown in Figure IA in the online-only Data Supplement, en face carotid artery preparations demonstrated highly efficient endothelial denudation of the carotid artery using a 0.014″ percutaneous transluminal coronary angioplasty guide wire as previously described. 12 In response to wire-induced carotid artery endothelial denudation injury, KLF10 expression was induced ≈2-fold in the BM and ≈3-fold in circulating peripheral blood mononuclear cells ( Figure 1A) . Remarkably, examination of KLF10 mRNA expression in lin − and lin + peripheral blood mononuclear cells demonstrated that KLF10 mRNA expression was strongly expressed in both lin − and lin − CD34 + cells by ≈13-fold and ≈2-fold, respectively, compared with lin + circulating cells. Furthermore, in response to carotid artery endothelial denudation, KLF10 mRNA expression increased in lin − and lin − CD34 + cells by ≈6-fold and ≈2-fold, respectively, compared with lin + circulating cells. To gain initial insights into whether KLF10 deficiency may impact reendothelialization, WT and systemic KLF10 −/− mice underwent wire-induced carotid artery endothelial denudation injury. The amount of reendothelialization in the carotids was determined after Evans blue systemic perfusion on days 0, 3, and 7 after injury. WT mice displayed higher areas of reendothelialization compared with KLF10 −/− mice (day 3: WT 52.4% versus KLF10 -/ -30.6%, P=0.045; day 7: WT 95.1% versus KLF10 −/− 75.1%, P=0.033; Figure 2A and 2B). In contrast, no differences were observed at day 0 after wire injury. Using thermal-induced carotid injury as a complementary strategy, a 3-mm segment proximal of the carotid artery was denuded and reendothelialization was verified after staining with Evans blue as described previously 13, 14 (Figure II in the online-only  Data Supplement) . Similar to the wire-induced model, reendothelialization was significantly reduced in KLF10 −/− mice compared with WT mice in response to thermal injury ( Figure  III in the online-only Data Supplement).
To examine the contribution of KLF10 from the BM, we performed BM transplantation studies and examined reendothelialization after 3 days in 4 groups (n=4-8 mice/group): WT BM into WT recipient mice (WT→WT), KLF10 −/− BM into WT recipient mice (KLF10 −/− →WT), WT BM into KLF10 −/− recipient mice (WT→KLF10 −/− ), and KLF10 −/− BM into KLF10 −/− recipient mice (KLF10 −/− →KLF10 −/− ). One month after BM reconstitution, wire-induced endothelial injury of the carotid arteries was performed, and reendothelialization areas were examined at 3 days. As shown in Figure 3 , WT mice reconstituted with KLF10 −/− BM displayed a 61% reduction in reendothelialization compared with WT mice reconstituted with WT BM; conversely, KLF10 −/− mice reconstituted with WT BM exhibited full recovery in reendothelialization. The reendothelialization areas were as follows: WT→WT 54.4%; KLF10 −/− →WT 21.1%; WT→KLF10 −/− 49.4%; and KLF10 −/− →KLF10 -/ -19.5%; n=5-8 mice/group). Taken together, these data indicate that BM-derived KLF10 expression confers a protective effect in establishing the neoendothelium after carotid artery endothelial denudation.
Accumulating studies demonstrate that circulating progenitors may contribute to vascular repair through direct incorporation in the vessel wall or via paracrine effects. 4, 15, 16 To examine the contribution of direct incorporation in the vessel wall, we performed sex-mismatched, Y-chromosome tracking studies after BM transplantation using female recipient mice reconstituted with male WT or KLF10 −/− donor BM cells. As shown in Figure 4 , the percentage of 4',6-diamidino-2-phenylindole cells that were Y chromosome positive in the injured carotid artery of mice reconstituted with KLF10-deficient cells showed a nonsignificant lower trend compared with mice reconstituted with WT cells (WT→WT, 9.83% of 3265 4',6-diamidino-2-phenylindole + cells versus KLF10 −/− →WT, 5.37% of 2050 4',6-diamidino-2-phenylindole + cells; P=0.069) as detected by fluorescence in situ hybridization. However, a closer examination of the carotid arteries, specifically for lin − progenitor cells, by flow cytometry revealed significant reductions in lin − CD34 + kinase insert domain receptor (KDR) + progenitors and lin − Sca-1 + KDR + progenitors by 38.2% and 24.4%, respectively ( Figure 5A and 5B), in WT mice reconstituted with KLF10 −/− BM, an effect that was completely rescued in KLF10 −/− mice reconstituted with WT BM. Similar findings were observed for these progenitors from peripheral blood mononuclear cells ( Figure 5C and 5D). These findings suggest that KLF10-deficient lin − BM progenitors may have intrinsic functional defects in their ability to be recruited into the vessel wall after injury.
To explore whether the progenitors derived from the BM of reconstituted mice may possess altered expression for key chemokine receptor markers implicated in BM mobilization and homing, flow cytometry was performed across the 4 groups. As shown in Figure 6A , WT mice reconstituted with KLF10 −/− BM ( Figure IVA in the online-only Data Supplement) had significantly reduced expression on lin − c-kit + CD34 + progenitors for CXC-chemokine receptor 4 (CXCR4) by 36.5%, a chemokine receptor implicated in EPC mobilization into tissues, 17 whereas there was only a modest decrease in a different chemokine receptor CC-chemokine receptor 7 (CCR7) (6.6%; Figure 6B ) or the vascular endothelial growth factor receptor KDR (19%; Figure IVB in the online-only Data Supplement). Furthermore, BM from KLF10 −/− mice reconstituted with WT BM completely rescued the reduction in CXCR4 and CCR7 expression ( Figure 6A and 6B). To investigate whether reduced expression for either CXCR4 or CCR7 may be associated with altered migratory responses, transwell Boyden chamber assays were performed using stromal cell-derived factor (SDF)-1α (ligand for CXCR4) and CCL21 (ligand for CCR7). As shown in Figure 6C and 6D, WT mice reconstituted with KLF10 −/− BM had lin − CD34 + progenitors, with decreased migratory responses by 24.3% and 29.2% for SDF-1α and CCL21, respectively. In contrast, BM from KLF10 −/− mice reconstituted with WT BM completely rescued the migratory defects in response to both ligands. In addition, BM lin − CD34 + progenitors from WT mice reconstituted with KLF10 −/− BM exhibited reduced adhesion to fibronectin-coated plates, whereas KLF10 −/− mice reconstituted with WT BM had no adhesion defects ( Figure 6E ). Finally, to explore the paracrine and trophic effects of KLF10 −/− BM lin − progenitors, media taken from each group of reconstituted BM progenitors grown in culture was used in 5-bromo-2'-deoxyuridine endothelial growth assays and migration studies. As shown in Figure 7A and 7B, media derived from KLF10 −/− BM progenitors exhibited reduced ability to promote EC growth and migration by ≈60% and ≈36%, respectively, compared with WT-reconstituted BM progenitors. Furthermore, KLF10 −/− -reconstituted BM progenitor cells also displayed reduced cell surface CXCR4 expression by flow cytometry and impaired migratory responses ( Figure V in the online-only Data Supplement). Collectively, these studies strongly implicate that KLF10deficient BM progenitors exhibit both intrinsic defects in their ability to migrate and incorporate into the vessel wall and extrinsic paracrine defects in their ability to facilitate EC growth and migration.
Discussion
The transcriptional events in the BM niche that help orchestrate vascular arterial reendothelialization after injury have not been well-defined. To our knowledge, this is the first experimental study addressing the importance of an endogenous transcription factor expressed in the BM on arterial reendothelialization. Our data show that KLF10 deficiency inhibits reendothelialization after endothelial denudation, an effect associated with reduced circulating progenitors in the blood and within the carotid artery. BM reconstitution studies demonstrated that KLF10 expression in the BM mediated both the reduced arterial reendothelialization and the reduced lin − progenitor cells in the periphery and injured carotid artery. In addition, these studies revealed that KLF10 −/− lin − progenitors exhibited impaired paracrine and trophic effects on ECs. Finally, KLF10 −/− lin − progenitors also displayed intrinsic defects in their ability to migrate, with markedly reduced expression for the chemokine receptor CXCR4.
Our studies indicate that KLF10 is a novel regulator of BM progenitor mobilization in response to endothelial injury. In support of these observations, progenitors from reconstituted mice with KLF10 −/− BM have reduced expression of chemokine receptors CXCR4 and to a modest extent CCR7. Indeed, KLF10 −/− BM progenitors had impaired migratory responses to their cognate ligands. Reduced expression of CXCR4, a critical receptor in regulating EPC homing and recruitment, has been associated with impaired progenitor homing to sites of endothelial injury, despite an increase of SDF-1 expression locally in injured areas after endothelial denudation. 18 Furthermore, disruption of SDF-1/CXCR4 signaling axis has been implicated in various pathophysiological contexts, such as vascular injury, left ventricular remodeling after myocardial infarction, myocardial regeneration, neovascularization, and wound healing. [18] [19] [20] [21] [22] [23] We have previously demonstrated that systemic deficiency of KLF10 markedly reduces blood flow recovery and neovascularization after hindlimb ischemia. 9 Whether, specifically, BM-derived KLF10 contributes to reparative functions in response to hindlimb ischemia or in the context of other cardiovascular injury states requires further study. KLF10 −/− BM progenitors also exhibited reduced adhesion properties, which may also adversely contribute to the endothelial reparative response. Taken together, these studies suggest that KLF10 positively regulates the BM response to arterial endothelial injury. These observations add to a growing list of factors that may contribute to BM progenitor cell mobilization and homing, including colony-stimulating factors (ie, granulocyte colony-stimulating factor, granulocyte-macrophage colonystimulating factor), growth factors (eg, vascular endothelial growth factor, transforming growth factor-β1), chemokines (eg, SDF-1), angiogenic factors (eg, angiopoietin-1, thrombospondin-1), hormones (eg, estrogen), drugs (eg, peroxisome proliferator-activated receptor γ agonists, statins, erythropoietins), and other regulators of the BM niche (eg, endothelial nitric oxide synthase, matrix metallopeptidase-9, parathyroid hormone). 17 Our previous studies revealed that in response to transforming growth factor-β1, KLF10 is induced in lin − BM progenitor subsets. 9 Whether KLF10 participates in the signaling of these other diverse stimuli to mediate specific ligand-triggered BM progenitor cell homing requires additional investigation.
Several studies have identified the presence of BM-derived progenitor cells in the vessel wall in response to vascular injury states, including carotid endothelial denudation, restenosis, atherosclerosis, and transplant arteriopathy. [24] [25] [26] [27] [28] [29] Several investigations have demonstrated the presence of BM-derived cells in the media and periadventitial regions where they may exert functional paracrine effects on reendothelialization and vascular repair. 20, 24, 27, [29] [30] [31] [32] [33] Furthermore, a recent study indicated that the frequency of BM progenitors directly accumulating in the neoendothelium of injured vessels is negligible. 34 We found decreased subsets of key circulating KLF10 −/− BM progenitor cells (lin − CD34 + KDR + and lin − Sca-1 + KDR + progenitors) in the vessel wall and revealed that the medium from cultured BM lin − KLF10 −/− progenitors exhibited impaired paracrine and trophic functions in their ability to promote EC migration and growth compared with WT lin − progenitors. Our findings are in keeping with the emerging concept that circulating progenitors are not a source for ECs during endothelial regeneration, whereas our studies highlight the importance of BM-derived progenitors for paracrine-mediated effects (eg, on the flanking noninjured ECs in the vasculature) and homing (eg, to periadventitial regions) in the reendothelialization response to vascular injury.
Finally, these findings bear several important clinical implications because delayed endothelial repair contributes prominently to the pathophysiology of stent thrombosis, stent restenosis, and prosthetic vascular graft disease. [1] [2] [3] In particular, reendothelialization is critically important for arterial healing after therapeutic angioplasty and stenting, and delayed reendothelialization has been implicated as a major cause of stent thrombosis after drug-eluting stent implantation. 35, 36 Current drug-eluting stent technologies prevent restenosis by releasing cytotoxic drugs that inhibit neointimal formation. Although these drugs prevent restenosis, they also delay reendothelialization, increasing risk of stent thrombosis. Indeed, human autopsy studies have shown that drug-eluting stent can have focal areas of defective reendothelialization years after initial stent placement. [37] [38] [39] Furthermore, as a result of the elevated risk of stent thrombosis with drug-eluting stent, current guidelines recommend extended treatment with antiplatelet therapies to reduce stent thrombosis risk. 35, 40 Because of the risk of delayed arterial healing with current technologies, there is intense focus on developing new therapies that both quench inflammation and promote vascular repair. Several strategies that augment the homing or function of circulating cells that promote reendothelialization are under evaluation in preclinical 41, 42 and clinical studies. [43] [44] [45] [46] [47] In this context, the findings, herein, that BM-derived KLF10 promotes arterial reendothelialization raises the possibility that increasing KLF10 expression or function may provide a novel strategy to accelerate reendothelialization after coronary stent placement. Diabetic subjects, in particular, have impaired endothelial repair mechanisms and are at higher risk for both stent thrombosis and stent restenosis. 48 Experimentally, diabetes mellitus reduces reendothelialization, 12, 49 and we previously demonstrated that KLF10 expression in lin − CD34 + circulating progenitors is reduced by ≈70% in diabetic human subjects compared with healthy subject controls. 9 Thus, strategies to increase KLF10 expression may have particular therapeutic potential in this vulnerable patient population.
In summary, in response to arterial endothelial denudation, KLF10 expression is increased in BM and circulating lin − progenitors. KLF10-deficient mice exhibit impaired reendothelialization and reduced circulating lin − progenitors in the periphery and injured carotid artery, effects mediated by KLF10 deficiency in the BM. KLF10 −/− BM lin − progenitors have both cell intrinsic and extrinsic defects that impair reendothelialization. These defects include reduced expression of CXCR4, which may underlie the reduced homing of these cells to injured sites, and paracrine defects that may underlie the attenuated trophic effects on cultured ECs. Taken together, our work demonstrates a critical role for KLF10 in regulating the BM response to endothelial injury and highlights a potential opportunity to target KLF10 for therapeutic intervention to improve endothelial repair. 
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